Vinca Alkaloids, Taxanes & Anticancer Antibiotics

Vinca Alkaloids, Taxanes & Anticancer Antibiotics

1. Definition, scope & place in the antineoplastic taxonomy

• Natural-product cytotoxics are antineoplastic agents derived from plants, microbes (Streptomyces soil bacteria) or marine organisms; G&G classifies them as a distinct family ("Section III — Natural Products") alongside alkylating agents/platinum complexes and antimetabolites (G&G 14e Ch.70, p.1343).
• The topic spans two mechanistically opposite super-groups:
  • Microtubule-damaging (antimitotic / "spindle poison") agents — vinca alkaloids, taxanes, and congeners (eribulin, estramustine, epothilones). They act on the mitotic spindle in M phase (G&G 14e Ch.70, pp.1363–5).
  • Antitumour antibiotics — anthracyclines/anthracenediones, dactinomycin, bleomycin, mitomycin. These are microbial fermentation products that injure DNA (intercalation, topoisomerase-II poisoning, free-radical strand scission, alkylation) across several cell-cycle phases (G&G 14e Ch.70, pp.1367–71; KDT 8e Ch.64, pp.926–7).
• KDT groups the same agents under two clinical headings — "Microtubule damaging agents" (vinca alkaloids + taxanes) and "Antibiotics" — and additionally lists the topoisomerase inhibitors (etoposide = topo-II; topotecan/irinotecan = topo-I) as separate plant-derived/semisynthetic classes (KDT 8e Ch.64, pp.924–6).
• Most agents in this topic are cell-cycle–specific (vincas, taxanes, eribulin = M phase; bleomycin accumulates cells in G₂); the antibiotics that injure DNA at multiple phases (anthracyclines, mitomycin, dactinomycin) are comparatively cycle-nonspecific in clinical behaviour (Golan 4e Ch.39, drug-summary table pp.746–9; G&G 14e Ch.69, "The Cell Cycle").